Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of the Purified Vero Rabies Vaccine – Serum Free vs Verorab in Pre-exposure Use in Healthy Adults
2009-009877-85Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2009
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of Purified Vero cell rabies vaccine in rabies (2 arms), sponsored by Sanofi. Primary endpoints: Seroconversion status at Day 42 and Clinical safety of VRVg. Started Jun 2009; status: completed.
02
Drugs
Purified Vero cell rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on 2009-009877-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009877-85.